NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/11/2023
Back to search
Official data from USPTO
ART PHARMA LUGOL'S
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ART PHARMA LUGOL'S
ST13
US500000097389817Class
5
Filing
97389817
Registration
7104102
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
07/11/2023
Trademark type
Word
Nice classes
5
Filing date
04/29/2022
Registration date
07/11/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/11/2023
Last transaction
07/11/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2015-00-00
First use in commerce
2015-00-00
Drawing code
4
Owner type
03
Owner location
Beauharnois, Quebec, CA
Examiner
ARRISON, RACHEL MARIE
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ART PHARMACEUTICAL LTD.
Representatives
Alexandra Summers SAUSSER SUMMERS, PC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Iodine
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/11/2023
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
06/07/2023
CNEA
EXAMINERS AMENDMENT MAILED
05/01/2023
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
04/07/2023
LOPT
LETTER OF PROTEST EVIDENCE FORWARDED
03/31/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/28/2023
PUBO
PUBLISHED FOR OPPOSITION
03/28/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/23/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
02/23/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/23/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
02/23/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/23/2023
DOCK
ASSIGNED TO EXAMINER
02/16/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/26/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/26/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/26/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/04/2022
NWAP
NEW APPLICATION ENTERED
05/03/2022
Continuous trademark protection
Get notified about every new filing that threatens ART PHARMA LUGOL'S or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.